Matches in Wikidata for { <http://www.wikidata.org/entity/Q82797859> ?p ?o ?g. }
Showing items 1 to 40 of
40
with 100 items per page.
- Q82797859 description "artículu científicu espublizáu en xunetu de 2012" @default.
- Q82797859 description "im Juli 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q82797859 description "scientific article published on 01 July 2012" @default.
- Q82797859 description "wetenschappelijk artikel" @default.
- Q82797859 description "наукова стаття, опублікована в липні 2012" @default.
- Q82797859 name "Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child" @default.
- Q82797859 name "Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child" @default.
- Q82797859 type Item @default.
- Q82797859 label "Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child" @default.
- Q82797859 label "Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child" @default.
- Q82797859 prefLabel "Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child" @default.
- Q82797859 prefLabel "Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child" @default.
- Q82797859 P1433 Q82797859-82BD3841-9FE5-4E91-B518-AB91EFB0337D @default.
- Q82797859 P1476 Q82797859-B70A8689-43AB-43B0-BC37-EA47C042BB78 @default.
- Q82797859 P2093 Q82797859-46CE7C5F-1C44-44D9-8F0C-9EEE54B8E8E1 @default.
- Q82797859 P304 Q82797859-DCB932D8-A9DA-49AB-A7BF-AA5B06EE57F3 @default.
- Q82797859 P31 Q82797859-2F508E15-6898-4647-A5A0-3782A42507AD @default.
- Q82797859 P356 Q82797859-2B989879-581A-4CA1-8910-07274AC51F5B @default.
- Q82797859 P433 Q82797859-EE8B2FF4-30EA-4D56-BE8A-9AC51D84FD85 @default.
- Q82797859 P478 Q82797859-BB8AEE35-B1C1-4D9A-9C3C-57FF96D51049 @default.
- Q82797859 P50 Q82797859-A8D10A62-145E-4602-B8AB-F9D39B22BC3E @default.
- Q82797859 P577 Q82797859-C5F12960-F50A-4C71-A05D-A37A3F624247 @default.
- Q82797859 P698 Q82797859-42C9B535-DC70-4504-BDE7-1DFAA0BAE12A @default.
- Q82797859 P921 Q82797859-3A1F7A39-4353-43AB-8DE3-08FFA4F6187E @default.
- Q82797859 P921 Q82797859-F8FA1786-1DF6-421B-BCD0-C2BF85E68E5D @default.
- Q82797859 P356 EJO.5000095 @default.
- Q82797859 P698 22139615 @default.
- Q82797859 P1433 Q15755023 @default.
- Q82797859 P1476 "Intravitreal bevacizumab for choroidal neovascularization secondary to Best vitelliform macular dystrophy in a 6-year-old child" @default.
- Q82797859 P2093 "Subhadra Jalali" @default.
- Q82797859 P304 "677-679" @default.
- Q82797859 P31 Q13442814 @default.
- Q82797859 P356 "10.5301/EJO.5000095" @default.
- Q82797859 P433 "4" @default.
- Q82797859 P478 "22" @default.
- Q82797859 P50 Q42177081 @default.
- Q82797859 P577 "2012-07-01T00:00:00Z" @default.
- Q82797859 P698 "22139615" @default.
- Q82797859 P921 Q413299 @default.
- Q82797859 P921 Q830265 @default.